| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| STJ enantiomers |
STJ對(duì)映異構(gòu)體 |
1207456-00-5 |
詳細(xì)
|
| Docetaxel Impurity E |
多西他賽雜質(zhì)E對(duì)照品 |
153381-68-1 |
詳細(xì)
|
| Docetaxel Impurity D |
多西他賽雜質(zhì)D對(duì)照品 |
167074-97-7 |
詳細(xì)
|
| Domperidone Impurity F |
多潘立酮雜質(zhì)F |
1391053-55-6 |
詳細(xì)
|
| Cangrelor tetrasodium impurity C-3 |
坎格雷洛四鈉雜質(zhì)C-3 |
163706-58-9 |
詳細(xì)
|
| Impurity I (clindamycin B palmitate) |
雜質(zhì)I(克林霉素B棕櫚酸酯) |
68206-99-5 |
詳細(xì)
|
| Benzophenone Azine |
二苯甲酮連氮 |
983-79-9 |
詳細(xì)
|
| (2-hydroxyethyl)ammonium dodecylsulphate |
月桂基硫酸酯單乙醇胺鹽 |
4722-98-9 |
詳細(xì)
|
| Amlodipine besylate impurity G |
苯磺酸氨氯地平雜質(zhì)G |
43067-01-2 |
詳細(xì)
|
| Hydroxyethyl phthalylamlodipine |
羥乙基鄰苯二甲胺氯地平 |
3079028-35-3 |
詳細(xì)
|
| Sodium Cyclopropanesulfinate |
環(huán)丙基亞磺酸鈉 |
910209-21-1 |
詳細(xì)
|
| BHA biphenyl type dimer |
BHA聯(lián)苯型二聚體 |
14078-41-2 |
詳細(xì)
|
| 1-chloro-10-iododecane |
1-氯-10-碘癸烷 |
57152-87-1 |
詳細(xì)
|
| 10-Iodo-1-decanol |
10-碘-1-癸醇 |
57395-49-0 |
詳細(xì)
|
| Orlistat Open Ring Impurity (2S,3S,5S)-Isomer |
奧利司他開環(huán)雜質(zhì)（2S，3S，5S）異構(gòu)體 |
130676-66-3 |
詳細(xì)
|
| Allyl acetoacetate |
京尼平苷酸 |
27741-01-1 |
詳細(xì)
|
| Abemaciclib Impurity |
阿貝西利雜質(zhì)A |
1627082-92-1 |
詳細(xì)
|
| (((S)-12-((R)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl)oxy)methyl methyl carbonate |
（（（S）-12-（（R）-7,8-二氟-6,11-二氫二苯并[b，e]噻平-11-基）-6,8-二氧基-3,4,6,8,12,12a-六氫-1H-[1,4]惡嗪[3,4-c]吡啶[2,1-f][1,2,4]三嗪-7-基）氧）甲基碳酸甲酯 |
3047100-07-9 |
詳細(xì)
|
| (R)-7-(benzyloxy)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione |
(R)-7-(芐氧基)-12-((S)-7,8-二氟-6,11-二氫二苯并[B,E]噻吩-11-基)-3,4,12,12A-四氫-1H-(1,4)噁嗪并[3,4-C]吡啶并[2,1-F][1,2,4]三嗪-6,8-二酮 |
1985606-53-8 |
詳細(xì)
|
| 1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 3,4,12,12a-tetrahydro-7-(phenylmethoxy)-, (12aS)- |
1H-[1,4]惡嗪[3,4-c]吡啶[2,1-f][1,2,4]三嗪-6,8-二酮，3,4,12,12a-四氫-7-（苯甲氧基）-，（12aS）- |
2762066-94-2 |
詳細(xì)
|
| 1H-[1,4]oxazine[3,4-C]pyridine[2,1-F][1,2,4]triazine-6,8-dione,12-[(11R)-7,8-difluoro-6,11-dihydrodibenzo[B,E]thiozapin-11-yl]-3,4,12,12A-tetrahydro-7-hydroxy-,(12AR)- |
1H-[1,4]惡嗪基[3,4-C]吡啶并[2,1-F][1,2,4]三嗪-6,8-二酮,12-[(11R)-7, 8-二氟-6,11-二氫二苯并[B,E]硫雜平-11-基]-3,4,12,12A-四氫-7-羥基-,(12AR)- |
2826217-70-1 |
詳細(xì)
|
| (R)-12-((R)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione |
（R）-12-（（R）-7,8-二氟-6,11-二氫二苯并[b，e]噻平-11-基）-7-（己氧基）-3,4,12,12a-四氫-1H-[1,4]惡嗪[3,4-c]吡啶[2,1-f][1,2,4]三嗪-6,8-二酮 |
2163287-88-0 |
詳細(xì)
|
| (4-Amino-phenyl)-methyl-carbamic acid tert-butyl ester |
(4-氨基苯基)甲基氨基甲酸叔丁酯 |
1092522-02-5 |
詳細(xì)
|
| 3-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]-1-methylpyridin-1-ium Iodide |
3-(4-己氧基-1,2,5-噻二唑-3-基)-1-甲基吡啶碘化物 |
131988-19-7 |
詳細(xì)
|
|
奧馬環(huán)素雜質(zhì)24 |
488818-72-0 |
詳細(xì)
|
|
N-亞硝基去甲基米諾環(huán)素2 |
28698-93-3 |
詳細(xì)
|
|
奧馬環(huán)素4-酮雜質(zhì) |
885112-31-2 |
詳細(xì)
|
|
奧馬環(huán)素M-2雜質(zhì) |
2272886-35-6 |
詳細(xì)
|
|
奧馬環(huán)素雜質(zhì)7 |
488819-64-3 |
詳細(xì)
|
|
奧馬環(huán)素4-Beta異構(gòu)體 |
601455-29-2 |
詳細(xì)
|
|
奧馬環(huán)素7-去甲基雜質(zhì) |
2272886-38-9 |
詳細(xì)
|
|
C12-13 醇乳酸酯對(duì)照品 |
93925-36-1 |
詳細(xì)
|
| Rizatriptan EP Impurity B |
利扎曲普坦EP雜質(zhì)B |
|
詳細(xì)
|
| Mivacurium Chloride Impurity D |
米庫氯銨雜質(zhì)D |
|
詳細(xì)
|
| Mivacurium Chloride Impurity C |
米庫氯銨雜質(zhì)C |
|
詳細(xì)
|
| Linagliptin Impurity 34 |
利格列汀雜質(zhì)34 |
|
詳細(xì)
|
| Ibrutinib Intermediate 2 Impurities 19 |
伊布替尼中間體2雜質(zhì)19 |
|
詳細(xì)
|
| 6-(2-chloro-5-fluoropyrimidine-4-yl)-4-fluoro-2-methyl-1H-benzo[d]imidazole |
6-(2-氯-5-氟嘧啶-4-基)-4-氟-2-甲基-1H-苯并[d]咪唑 |
|
詳細(xì)
|
| No flupitivat triphenylphosphine |
無氟匹伐三苯基膦 |
|
詳細(xì)
|
| 4-Amino-N-nitroso-N-methylaniline |
4-氨基-N-亞硝基-N-甲基苯胺 |
|
詳細(xì)
|
| Sodium pantothenate impurity E calcium salt |
泛酸鈉雜質(zhì)E鈣鹽 |
|
詳細(xì)
|